• Login
• Admin

Russo, Emanuele (2020) Bio-responsive hydrogels for an in vitro brain cancer cell model: self-controlled inhibition of matrix metalloproteinase activity. PhD thesis, University of Nottingham.

Preview

PDF (Thesis - as examined) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Available under Licence All Rights Reserved. Download (6MB) | Preview

Abstract

In nature, an unbalanced level of enzyme activity (e.g. proteases) is correlated to various disease states, particularly cancer. Among them, several studies have established that medulloblastoma (MB), a brain cancer in children, is associated with an overexpression of matrix metalloproteases (MMPs) (predominantly MMP-2), which is the consequence of the downregulation of their natural inhibitors tissue inhibitors of matrix metalloproteases (TIMPs) (e.g. TIMP-2). Although MMP inhibition remains a relevant therapeutic approach, MMP synthetic inhibitors have not converted to clinical application due to their dose-limiting side effects following systemic administration. As a result, the controlled delivery of endogenous MMP inhibitors directly in situ, could therefore provide the re-establishment of the MMP/TIMP equilibrium.

The main goal of this work is to develop a MMP-2 responsive hydrogel that could provide an on-demand controlled release of the recombinant tissue inhibitor of MMP-2 (rTIMP-2) in response to elevated MMP-2 activity. This could be beneficial to restore the enzyme/inhibitor equilibrium and provide reduction of tumour growth and metastasis.

MMP-2 responsive hydrogels were fabricated through thiol-ene step-growth polymerization of multiarm PEG-norbornene (PEG4-NB) with a MMP-2 recognised peptide sequence. Hydrogels demonstrated their MMP-2 sensitivity through the release of an encapsulated fluorescent dextran probe, as crosslinks are degraded by the enzyme. Following mesh size optimisation using a model dithiothreitol (DTT) cross-linked PEG4-NB hydrogel, MMP-2 responsive hydrogels were found to proficiently encapsulate and retain rTIMP-2, a necessary condition to maintain an exclusively enzyme triggered release. rTIMP-2 loaded hydrogels demonstrated their ability to efficiently inhibit different levels of MMP-2 and to modulate enzyme activity on the basis of the different rTIMP-2 payloads. These outcomes were obtained by monitoring both the residual MMP-2 activity and the subsequent release of a co-encapsulated fluorescent dextran upon MMP-2 action. Lastly, in a preliminary study, rTIMP-2 containing hydrogels proved to be cell biocompatible and able to inhibit MMP-2 secreted by MB cells.

These findings promote the potential ability of this bio-responsive hydrogel to promote the renewal of the imbalance between MMP-2 and TIMP-2, an essential condition to reduce medulloblastoma growth.

Item Type:	Thesis (University of Nottingham only) (PhD)
Supervisors:	Zelzer, Mischa/ M.Z Mantovani, Giuseppe / G.M. Chan, Weng / W.C. Coyle, Beth / B.C. Ashford, Marianne / M.A. Gellert, Paul / P.G.
Keywords:	cancer cells, enzymes, metalloproteinases, hydrogels
Subjects:	Q Science > QP Physiology > QP501 Animal biochemistry R Medicine > RC Internal medicine > RC 254 Neoplasms. Tumors. Oncology (including Cancer)
Faculties/Schools:	UK Campuses > Faculty of Science > School of Pharmacy
Item ID:	60290
Depositing User:	Russo, Emanuele
Date Deposited:	12 Oct 2023 14:21
Last Modified:	28 Feb 2025 14:52
URI:	https://eprints.nottingham.ac.uk/id/eprint/60290

Actions (Archive Staff Only)

Edit View